Basch's study, which included 766 patients at Memorial Sloan Kettering Cancer Center in New York, tested a simple web-based tool. Patients who were undergoing treatment for cancer used a computer program to report any symptoms, side effects, ...
About CAR-T leukemia therapy, part of a new wave in cancer treatment
A U.S. Food and Drug Administration advisory panel endorsed a new breakthrough therapy for advanced leukemia on Wednesday called CTL019 –- a first-of-its-kind cancer treatment, in an emerging category known as CAR-T immunotherapy. The treatment ...
No comments:
Post a Comment